BENDAMUSTINE IN COMBINATION WITH RITUXIMAB AS FIRST LINE THERAPY FOR PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): A RETROSPECTIVE REAL PRACTICE ITALIAN MULTICENTRE STUDY

被引：0
|
作者：
Gentile, M. [1 ]
Ciolli, S. [2 ]
Molica, S. [3 ]
Di Renzo, N. [4 ]
Selleri, C. [5 ]
Villa, M. R. [6 ]
De Paolis, M. R. [4 ]
Scortechini, I. [7 ]
Giannotta, A. [8 ]
Minoia, C. [9 ]
Boncompagni, R. [2 ]
Bonanno, V. [10 ]
Levato, L. [3 ]
Musso, M. [10 ]
Mastrullo, L. [6 ]
Melpignano, A. [8 ]
Murru, R. [11 ]
Angelucci, E. [11 ]
Caparrotti, G. [1 ,2 ,12 ]
Guarini, A. [1 ,3 ,13 ]
Pinto, A. [1 ,4 ,14 ]
Ferrara, F. [1 ,5 ,15 ]
Zinzani, P. [1 ,6 ,16 ]
Morabito, F. [1 ,7 ,17 ]
机构：
[1] UOC Ematol Cosenza, Cosenza, Italy
[2] Azienda Osped Univ Careggi, SODC Ematol, Florence, Italy
[3] Pugliese Ciaccio Hosp, Dept Oncol & Haematol, Catanzaro, Italy
[4] Osped Vito Fazzi, Hematol Unit, Lecce, Italy
[5] Univ Salerno, Hematol & SCT Transplant Ctr, Dept Med, AOU San Giovanni Dio & Ruggi Aragona, I-84100 Salerno, Italy
[6] UOC Ematol PO San Gennaro Napoli, Naples, Italy
[7] AO Osped Riuniti Marche, Div Ematol, Ancona, Italy
[8] Osped Antonio Perrino Brindisi, UOC Ematol, Brindisi, Italy
[9] IRCCS Ist Tumori Giovanni Paolo II Bari, UOC Ematol, Bari, Italy
[10] UO Ematol & Trapianto Midollo Osseo La Maddalena, Palermo, Italy
[11] A Businco Cagliari, UO Ematol Osped Oncol, Cagliari, Italy
[12] PO G Moscati Aversa, UO Ematol, Aversa, Italy
[13] IRCCS Ist Tumori Giovanni Paolo II Bari, UOC Ematol, Bari, Italy
[14] IRCCS Fdn G Pascale Napoli, SC Ematol Oncol INT, Naples, Italy
[15] Osped Cardarelli Napoli, Div Ematol, Naples, Italy
[16] L&A Seragnoli Bologna, Inst Hematol & Med Oncol, Bologna, Italy
[17] UOC Ematol Cosenza, Cosenza, Italy
来源：
HAEMATOLOGICA | 2014年 / 99卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PB1503
引用
收藏
页码：584 / 584
页数：1
相关论文
共 50 条
  • [31] Phase-II-study of rituximab in combination with fludarabine in patients (pts) with chronic lymphocytic leukemia (CLL).
    Schulz, H
    Klein, SK
    Rehwald, U
    Reiser, M
    Ibach, S
    Aulitzky, WE
    Hensel, M
    Herold, M
    Huhn, D
    Knauf, U
    Hallek, M
    Diehl, V
    Engert, A
    BLOOD, 2001, 98 (11) : 364A - 364A
  • [32] Rituximab and Campath-1H combination therapy in patients with relapsed and/or refractory chronic lymphocytic leukemia (CLL).
    Nabhan, C
    Patton, D
    Gordon, LI
    Riley, MB
    Kuzel, T
    Tallman, MS
    Rosen, ST
    BLOOD, 2003, 102 (11) : 361B - 361B
  • [33] Postremissional rituximab administration for the treatment of older chronic lymphocytic leukemia (CLL) patients responsive to first line therapy with chlorambucil and prednisone.
    Mauro, FR
    Gentile, M
    De Propris, MS
    Giammartini, E
    Buffolino, S
    Ghia, M
    Paoloni, F
    Valle, V
    Guarini, AR
    Alimena, G
    Mandelli, F
    Foa, R
    BLOOD, 2003, 102 (11) : 674A - 674A
  • [34] Chronic Lymphocytic Leukemia (CLL) The choice of a BTKl in first and second line therapy
    Schmale, Ine
    ONCOLOGY RESEARCH AND TREATMENT, 2024, 47 (1-2)
  • [35] Combination of bendamustine and rituximab as salvage therapy for patients with relapsed or refractory chronic lymphocytic leukemia: Experience of single center in Russia
    Semochkin, S.
    Ivanova, V. L.
    Lukina, A. I.
    Mukha, L. A.
    Arshanskaya, E. G.
    Lazarev, I. E.
    Kulikova, S. S.
    Pochtar, M. E.
    Huazheva, N. K.
    Markaryan, V. G.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S853 - S853
  • [36] Bendamustine and rituximab combination in the management of chronic lymphocytic leukemia-associated autoimmune hemolytic anemia: A multicentric retrospective study of the French CLL intergroup (GCFLLC/MW and GOELAMS)
    Quinquenel, Anne
    Willekens, Christophe
    Dupuis, Jehan
    Royer, Bruno
    Ysebaert, Loic
    De Guibert, S.
    Michallet, Anne-Sophie
    Feugier, Pierre
    Guieze, Romain
    Levy, Vincent
    Delmer, Alain
    AMERICAN JOURNAL OF HEMATOLOGY, 2015, 90 (03) : 204 - 207
  • [37] Lenalidomide added to bendamustine-rituximab for untreated chronic lymphocytic leukemia (CLL): A phase 1 study.
    Abramson, Jeremy S.
    Davids, Matthew Steven
    Werner, Lillian
    Fisher, David Christopher
    Armand, Philippe
    Amrein, Philip C.
    Neuberg, Donna S.
    Hochberg, Ephraim P.
    Brown, Jennifer R.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [38] Immunochemotherapy with rituximab in combination with fludarabine and epirubicine as first-line treatment in patients with chronic lymphocytic leukemia
    Chow, K. U.
    Kim-Wanner, S.
    Hermann, S.
    Wunderle, L.
    Cordes, H. J.
    Bergmann, L., Sr.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [39] Efficacy Of Bendamustine and Rituximab In Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia
    Kataeva, Elena
    Golenkov, Anatoly
    Triphonova, Elena
    Dudina, Galina
    Mitina, Tatyana
    Lutskaya, Tatyana
    Vysotskaya, Ludmila
    Chernykh, Yulliya
    Zakharov, Sergey
    BLOOD, 2013, 122 (21)
  • [40] Rituximab in Combination with Bendamustine or Chlorambucil for Treating Patients with Chronic Lymphocytic Leukemia: Interim Results of a Phase IIIb Study (MaBLe).
    Leblond, Veronique
    Laribi, Kamel
    Ilhan, Osman
    Aktan, Melih
    Unal, Ali
    Rassam, Saad M. B.
    Schuh, Anna
    Widenius, Tom
    Johansson, Peter
    Raposo, Joao
    Meddeb, Balkis
    Moreno, Carol
    Oertel, Stephan H. K.
    Michallet, Anne-Sophie
    BLOOD, 2012, 120 (21)
12345